[go: up one dir, main page]

AU2020900782A0 - Treatment Methods - Google Patents

Treatment Methods

Info

Publication number
AU2020900782A0
AU2020900782A0 AU2020900782A AU2020900782A AU2020900782A0 AU 2020900782 A0 AU2020900782 A0 AU 2020900782A0 AU 2020900782 A AU2020900782 A AU 2020900782A AU 2020900782 A AU2020900782 A AU 2020900782A AU 2020900782 A0 AU2020900782 A0 AU 2020900782A0
Authority
AU
Australia
Prior art keywords
treatment methods
treatment
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2020900782A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NewSouth Innovations Pty Ltd
Original Assignee
NewSouth Innovations Pty Ltd
Filing date
Publication date
Application filed by NewSouth Innovations Pty Ltd filed Critical NewSouth Innovations Pty Ltd
Publication of AU2020900782A0 publication Critical patent/AU2020900782A0/en
Priority to JP2022555832A priority Critical patent/JP2023518375A/en
Priority to PCT/AU2021/050219 priority patent/WO2021184059A1/en
Priority to CA3171779A priority patent/CA3171779A1/en
Priority to EP21771600.0A priority patent/EP4117655A4/en
Priority to US17/906,288 priority patent/US20240050444A1/en
Priority to AU2021238880A priority patent/AU2021238880A1/en
Pending legal-status Critical Current

Links

AU2020900782A 2020-03-14 2020-03-14 Treatment Methods Pending AU2020900782A0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
JP2022555832A JP2023518375A (en) 2020-03-14 2021-03-12 Method of treatment
PCT/AU2021/050219 WO2021184059A1 (en) 2020-03-14 2021-03-12 Treatment methods
CA3171779A CA3171779A1 (en) 2020-03-14 2021-03-12 Compounds and pharmaceutical compositions for reducing vascular permeability,neovascularisation,angiogenesis,inflammation,cell migration and/or cell proliferation,and to methods for inhibiting fosb/.delta.fosb expression and/or erk1/2 phosphorylation and/or vcam-1 expression.
EP21771600.0A EP4117655A4 (en) 2020-03-14 2021-03-12 TREATMENT PROCEDURES
US17/906,288 US20240050444A1 (en) 2020-03-14 2021-03-12 Treatment methods
AU2021238880A AU2021238880A1 (en) 2020-03-14 2021-03-12 Treatment methods

Publications (1)

Publication Number Publication Date
AU2020900782A0 true AU2020900782A0 (en) 2020-03-26

Family

ID=

Similar Documents

Publication Publication Date Title
AU2022298331B2 (en) Methods
EP3991718A4 (en) Hair treatment method
EP3856241A4 (en) Treatment methods
EP4175574A4 (en) Treatment apparatus
AU2020900782A0 (en) Treatment Methods
HK40111969A (en) Treatment
HK40089721A (en) Combination treatment
HK40115121A (en) Mirdametinib treatment
AU2021904108A0 (en) Treating COVID
HK40105578A (en) Therapeutic methods
HK40085565A (en) Cancer treatment methods
AU2019900337A0 (en) Treatment Methods
AU2019901677A0 (en) Treatment Method
AU2022901482A0 (en) Combination treatment
HK40066948A (en) Methods of treatment
HK40075476A (en) Methods of treatment
AU2019900083A0 (en) Treatment Method
HK40101862A (en) Treatment agent
EP4349338A4 (en) Treatment agent
AU2019901563A0 (en) Patient treatment method
HK40089794A (en) Methods for treating covid-19
AU2021375388A9 (en) Treatment support
HK40110626A (en) Methods
HK40107683A (en) Methods
HK40104531A (en) Methods of treatment